SCHEMBL932950

SCHEMBL932950

COC(=O)C(C(C)=O)C(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 5/20 0.44
CA14 Q9ULX7 2/20 0.39
ALOX15 P16050 1/20 0.37
CA12 O43570 1/20 0.36
KMT2A Q03164 1/20 0.36
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
ZDHHC7 Q9NXF8 1/20 0.32
TSHR P16473 2/20 0.32
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1335337 0.94 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1CA14ALOX15CA12
SCHEMBL2912889 0.86 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1CA14ALOX15CA12
SCHEMBL422851 0.83 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1CA14CA12KMT2A
SCHEMBL6933551 0.80 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1CA14ALOX15CA12
SCHEMBL14375225 0.80 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1ALOX15KMT2AMGAM
SCHEMBL10485422 0.80 CA1 (0.36) SMN1; SMN2ALDH1A1CA14ALOX15MMP2
SCHEMBL16502244 0.80 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1CA14ALOX15MMP2
SCHEMBL23803859 0.78 CA1 (0.36) SMN1; SMN2ALDH1A1CA14ALOX15CA12
SCHEMBL2202923 0.78 ALDH1A1 (0.37) SMN1; SMN2ALDH1A1CA14ALOX15CA12
SCHEMBL9788243 0.78 MGAM (0.46) SMN1; SMN2ALDH1A1CA14ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7560550-B2 Method for the production of OH protected[4-(2.6-diamino-9H-purine-9-yl)-1.3-dioxolane-2-yl]methanol derivatives RFS PHARMA, LLC (US) 2009-07-14 US claimed
EP-0912467-B1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE SA (FR) 2002-04-24 EP claimed
EP-0912467-A1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE (FR) 1999-05-06 EP claimed
WO-1998000375-A1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE (FR) 1998-01-08 WO claimed
US-20240360068-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-10-31 US disclosed
US-20230265041-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND TEHIR USES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-08-24 US disclosed
US-11687003-B2 Negative resist pattern-forming method, and composition for upper layer film formation JSR CORPORATION (JP) 2023-06-27 US disclosed
EP-3365380-B1 VINYL CHLORIDE POLYMERS AND COMPOSITIONS FOR ADDITIVE MANUFACTURING AKDENIZ CHEMSON ADDITIVES AG (AT) 2023-04-26 EP disclosed
US-11608309-B2 Curcumin analogues as zinc chelators and their uses THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-03-21 US disclosed
US-11542389-B2 Vinyl chloride polymers and compositions for additive manufacturing AKDENIZ CHEMSON ADDITIVES AG (AT) 2023-01-03 US disclosed
US-20210053905-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2021-02-25 US disclosed
US-20210017374-A1 VINYL CHLORIDE POLYMERS AND COMPOSITIONS FOR ADDITIVE MANUFACTURING AKDENIZ CHEMSON ADDITIVES AG (AT) 2021-01-21 US disclosed
US-5424421-A Synthesis of carminic acid and principal intermediates EUROPEAN COLOUR PLC (GB) 1995-06-13 US disclosed
EP-0602027-A1 SYNTHESIS OF CARMINIC ACID AND PRINCIPAL INTERMEDIATES. EUROP COLOUR PLC (GB) 1994-06-22 EP disclosed
EP-0297752-B1 PROCESS OF PREPARING OPTICALLY ACTIVE ALCOHOL Takasago International Corporation (JP) 1992-09-16 EP disclosed
US-5144057-A Process for the production of 3-oxocarboxylic acid esters LONZA LTD. (CH) 1992-09-01 US disclosed
WO-1992001664-A1 SYNTHESIS OF CARMINIC ACID AND PRINCIPAL INTERMEDIATES EUROPEAN COLOUR PLC (GB) 1992-02-06 WO disclosed
US-4916252-A OPTICALLY ACTIVE PHOSPHINE-RUTHENIUM HYDROGENATION CATALYST TAKASAGO INTERNATIONAL CORPORATION (JP) 1990-04-10 US disclosed
EP-0297752-A2 Process of preparing optically active alcohol Takasago International Corporation (JP) 1989-01-04 EP disclosed
US-4107133-A ORGANIC PIGMENT, ORGANOSILANE OR ORGANOTITANIUM COMPOUND DAINIPPON INK & CHEMICALS, INC. (JP) 1978-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265041-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND TEHIR USES NFRKB, NFKBIA, NFKB1 SMN1; SMN2 4301/4885ALDH1A1 1929/4885CA14 2432/4885
US-11608309-B2 Curcumin analogues as zinc chelators and their uses NFKBIA, NFKB1, NFKB2 SMN1; SMN2 3825/4885ALDH1A1 966/4885CA14 2192/4885
US-20210053905-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES NFKBIA, NFKB1, NFKB2 SMN1; SMN2 3825/4885ALDH1A1 966/4885CA14 2192/4885
US-20240360068-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES NFKBIA, NFKB1, NFKB2 SMN1; SMN2 3825/4885ALDH1A1 966/4885CA14 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.